Differential 14-3-3σ DNA methylation and expression in c-myc- and activated H-ras-transformed cells under r- and K-selection

Cancer Letters

Volumn 236, Issue 1, 2006, Pages 105-114

  Sato, Hiroyuki ^a   Nakamura, Yukari ^a   Motokura, Toru ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

14 3 3; DNA methylation; Multistep tumorigenesis; Natural selection; Stratifin

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; DNA; MYC PROTEIN; PROTEIN 14 3 3; PROTEIN P53;

ANIMAL CELL; ARTICLE; BREAST CANCER; CLONE; CONTROLLED STUDY; DNA METHYLATION; EMBRYO; FIBROBLAST; GENE OVEREXPRESSION; MOLECULAR CLONING; NONHUMAN; ONCOGENE H RAS; PANCREAS CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RAT STRAIN; TUMOR SUPPRESSOR GENE;

14-3-3 PROTEINS; ANIMALS; CELL LINE, TRANSFORMED; CELL TRANSFORMATION, NEOPLASTIC; CLONING, MOLECULAR; DNA METHYLATION; EVOLUTION, MOLECULAR; GENE EXPRESSION REGULATION; GENETIC VECTORS; HUMANS; MODELS, GENETIC; PROTEIN ISOFORMS; PROTO-ONCOGENE PROTEINS C-MYC; PROTO-ONCOGENE PROTEINS P21(RAS); RATS; RNA, MESSENGER; TRANSFECTION;

ANIMALIA;

EID: 33646107867     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2005.05.004     Document Type: Article

References (37)

1. Leffers H., Madsen P., Rasmussen H.H., Honore B., Andersen A.H., Walbum E., et al. Molecular cloning and expression of the transformation sensitive epithelial marker stratifin. A member of a protein family that has been involved in the protein kinase C signalling pathway. J. Mol. Biol. 231 (1993) 982-998
2. Dellambra E., Golisano O., Bondanza S., Siviero E., Lacal P., Molinari M., et al. Downregulation of 14-3-3σ prevents clonal evolution and leads to immortalization of primary human keratinocytes. J. Cell Biol. 149 (2000) 1117-1130
3. Chan T.A., Hermeking H., Lengauer C., Kinzler K.W., and Vogelstein B. 14-3-3σ is required to prevent mitotic catastrophe after DNA damage. Nature 401 (1999) 616-620
4. Hermeking H., Lengauer C., Polyak K., He T.C., Zhang L., Thiagalingam S., et al. 14-3-3σ is a p53-regulated inhibitor of G2/M progression. Mol. Cell 1 (1997) 3-11
5. Ferguson A.T., Evron E., Umbricht C.B., Pandita T.K., Chan T.A., Hermeking H., et al. High frequency of hypermethylation at the 14-3-3 σ locus leads to gene silencing in breast cancer. Proc. Natl. Acad. Sci. USA 97 (2000) 6049-6054
6. Umbricht C.B., Evron E., Gabrielson E., Ferguson A., Marks J., and Sukumar S. Hypermethylation of 14-3-3 σ (stratifin) is an early event in breast cancer. Oncogene 20 (2001) 3348-3353
7. Urano T., Saito T., Tsukui T., Fujita M., Hosoi T., Muramatsu M., et al. Efp targets 14-3-3σ for proteolysis and promotes breast tumour growth. Nature 417 (2002) 871-875
8. Suzuki H., Itoh F., Toyota M., Kikuchi T., Kakiuchi H., and Imai K. Inactivation of the 14-3-3 σ gene is associated with 5′ CpG island hypermethylation in human cancers. Cancer Res. 60 (2000) 4353-4357
9. Osada H., Tatematsu Y., Yatabe Y., Nakagawa T., Konishi H., Harano T., et al. Frequent and histological type-specific inactivation of 14-3-3σ in human lung cancers. Oncogene 21 (2002) 2418-2424
10. Lodygin D., Yazdi A.S., Sander C.A., Herzinger T., and Hermeking H. Analysis of 14-3-3σ expression in hyperproliferative skin diseases reveals selective loss associated with CpG-methylation in basal cell carcinoma. Oncogene 22 (2003) 5519-5524
11. Samuel T., Weber H.O., Rauch P., Verdoodt B., Eppel J.T., McShea A., et al. The G2/M regulator 14-3-3σ prevents apoptosis through sequestration of Bax. J. Biol. Chem. 276 (2001) 45201-45206
12. Ide M., Nakajima T., Asao T., and Kuwano H. Inactivation of 14-3-3σ by hypermethylation is a rare event in colorectal cancers and its expression may correlate with cell cycle maintenance at the invasion front. Cancer Lett. 207 (2004) 241-249
13. Iacobuzio-Donahue C.A., Maitra A., Olsen M., Lowe A.W., van Heek N.T., Rosty C., et al. Exploration of global gene expression patterns in pancreatic adenocarcinoma using cDNA microarrays. Am. J. Pathol. 162 (2003) 1151-1162
14. Logsdon C.D., Simeone D.M., Binkley C., Arumugam T., Greenson J.K., Giordano T.J., et al. Molecular profiling of pancreatic adenocarcinoma and chronic pancreatitis identifies multiple genes differentially regulated in pancreatic cancer. Cancer Res. 63 (2003) 2649-2657
15. Momparler R.L. Cancer epigenetics. Oncogene 22 (2003) 6479-6483
16. Feinberg A.P., and Tycko B. The history of cancer epigenetics. Nat. Rev. Cancer 4 (2004) 143-153
17. Li E., Bestor T.H., and Jaenisch R. Targeted mutation of the DNA methyltransferase gene results in embryonic lethality. Cell 69 (1992) 915-926
18. Li E., Beard C., and Jaenisch R. Role for DNA methylation in genomic imprinting. Nature 366 (1993) 362-365
19. Panning B., and Jaenisch R. RNA and the epigenetic regulation of X chromosome inactivation. Cell 93 (1998) 305-308
20. MacArthur R.H., and Wilson E.O. The Theory of Island Biogeography (1967), Princeton University Press, Princeton, NJ
21. Chikatsu N., Nakamura Y., Sato H., Fujita T., Asano S., and Motokura T. p53 mutations and tetraploids under r- and K-selection. Oncogene 21 (2002) 3043-3049
22. Morita S., Kojima T., and Kitamura T. Plat-E: an efficient and stable system for transient packaging of retroviruses. Gene Ther. 7 (2000) 1063-1066
23. Onishi M., Kinoshita S., Morikawa Y., Shibuya A., Phillips J., Lanier L.L., et al. Applications of retrovirus-mediated expression cloning. Exp. Hematol. 24 (1996) 324-329
24. Nosaka T., Kawashima T., Misawa K., Ikuta K., Mui A.L., and Kitamura T. STAT5 as a molecular regulator of proliferation, differentiation and apoptosis in hematopoietic cells. Eur. Mol. Biol. Org. J. 18 (1999) 4754-4765
25. Kitamura T., and Morikawa Y. Isolation of T-cell antigens by retrovirus-mediated expression cloning. Methods Mol. Biol. 134 (2000) 143-152
26. Uchimaru K., Taniguchi T., Yoshikawa M., Asano S., Arnold A., Fujita T., et al. Detection of cyclin D1 (bcl-1, PRAD1) overexpression by a simple competitive reverse transcription-polymerase chain reaction assay in t(11;14)(q13;q32)-bearing B-cell malignancies and/or mantle cell lymphoma. Blood 89 (1997) 965-974
27. Uchimaru K., Taniguchi T., Yoshikawa M., Fujinuma H., Fujita T., and Motokura T. Growth arrest associated with 12-o-tetradecanoylphorbol-13-acetate-induced hematopoietic differentiation with a defective retinoblastoma tumor suppressor-mediated pathway. Leuk. Res. 22 (1998) 413-420
28. Herman J.G., Graff J.R., Myohanen S., Nelkin B.D., and Baylin S.B. Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc. Natl. Acad. Sci. U. S. A. 93 (1996) 9821-9826
29. Ushijima T., Watanabe N., Okochi E., Kaneda A., Sugimura T., and Miyamoto K. Fidelity of the methylation pattern and its variation in the genome. Genome Res. 13 (2003) 868-874
30. Karpf A.R., Moore B.C., Ririe T.O., and Jones D.A. Activation of the p53 DNA damage response pathway after inhibition of DNA methyltransferase by 5-aza-2′-deoxycytidine. Mol. Pharmacol. 59 (2001) 751-757
31. Hermeking H. The 14-3-3 cancer connection. Nat. Rev. Cancer 3 (2003) 931-943
32. Ranniger K., and Saldino R.M. Arteriographic diagnosis of pancreatic lesions. Radiology 86 (1966) 470-474
33. Guweidhi A., Kleeff J., Giese N., Fitori J.E., Ketterer K., Giese T., et al. Enhanced expression of 14-3-3sigma in pancreatic cancer and its role in cell cycle regulation and apoptosis. Carcinogenesis 25 (2004) 1575-1585
34. Zhang Y., Karas M., Zhao H., Yakar S., and LeRoith D. 14-3-3σ mediation of cell cycle progression is p53-independent in response to insulin-like growth factor-I receptor activation. J. Biol. Chem. 279 (2004) 34353-34360
35. Jones P.A. DNA methylation errors and cancer. Cancer Res. 56 (1996) 2463-2467
36. Graff J.R., Gabrielson E., Fujii H., Baylin S.B., and Herman J.G. Methylation patterns of the E-cadherin 5′ CpG island are unstable and reflect the dynamic, heterogeneous loss of E-cadherin expression during metastatic progression. J. Biol. Chem. 275 (2000) 2727-2732
37. Jones P.A. DNA methylation and cancer. Oncogene 21 (2002) 5358-5360